Related Experiment Video
Updated: May 23, 2026

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
Published on: July 27, 2022
Preparation, characterization, sterility validation, and in vitro cell toxicity studies of microemulsions possessing
Jerry Nesamony1, Carrie L Zachar, Rose Jung
1Department of Pharmacy Practice, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH 43614, USA. jerry.nesamony@utoledo.edu
Context:
Water-in-oil microemulsions (w/o ME) are ideal for parenteral drug delivery. However, no such formulations have been tested for biocompatibility in in vitro cell cultures. Furthermore, sterilization of w/o MEs is a challenging process that has not been previously developed and validated.
Purpose:
To formulate pharmaceutically relevant water-in-oil (w/o) microemulsion's systems suitable for use as a parenteral formulation.
Methods:
w/o MEs were prepared using dioctyl sodium sulfosuccinate (DOSS), ethyl oleate (EO), and water. Formulations were characterized using polarized light microscopy, electrical conductivity, rheology, and dynamic light scattering. An aseptic filtration method for sterilization was developed using membrane filtration. The biocompatibility of selected MEs were evaluated in NIH3T3 cell cultures. Dissolution studies were performed on microemulsions containing methylene blue to evaluate the drug release profile.
Results:
The maximum amount of water incorporated in the formulations was 14% w/w. DOSS/EO/water microemulsions exhibited Newtonian flow. Particle sizes for these MEs were less than 30 nm in size. Formulations filtered aseptically were free of bacteria when gram-stained and visualized under a microscope. All MEs showed no toxicity to NIH 3T3 cells.
Discussion:
The absence of birefringence and low conductivity values indicated that the formulations were w/o microemulsions. The filtration method of sterilization was validated by the absence of microbial growth on blood agar plates over a 14-day period. In vitro dye release studies demonstrate sustained release of the model drug over a 72-h time period.
Conclusion:
Characteristics delineated in this study demonstrate the potential for these formulations to be used as parenteral preparations.
Insights
This study developed sterile water-in-oil microemulsions for parenteral delivery, demonstrating their biocompatibility and sustained drug release. These novel formulations show promise for safe and effective intravenous drug administration.
Area of Science:
- Pharmaceutical Sciences
- Nanotechnology
- Biocompatibility Studies
Background:
- Water-in-oil microemulsions (w/o MEs) are promising for parenteral drug delivery.
- Challenges include lack of biocompatibility data and validated sterilization methods for w/o MEs.
Purpose of the Study:
- To formulate pharmaceutically relevant w/o microemulsions for parenteral applications.
- To develop and validate a sterilization method for w/o MEs.
- To assess the biocompatibility and drug release profiles of these microemulsions.
Main Methods:
- Formulation of w/o MEs using dioctyl sodium sulfosuccinate (DOSS) and ethyl oleate (EO).
- Characterization via polarized light microscopy, conductivity, rheology, and dynamic light scattering.
- Development of aseptic membrane filtration for sterilization and biocompatibility testing in NIH3T3 cell cultures.
Main Results:
- Successfully incorporated up to 14% water into DOSS/EO/water microemulsions.
- Characterized MEs exhibited Newtonian flow and particle sizes under 30 nm.
- Sterilized MEs were bacteria-free, and all formulations showed no toxicity to NIH3T3 cells.
Conclusions:
- Validated aseptic filtration method ensures sterile w/o microemulsions.
- In vitro studies confirm biocompatibility and sustained drug release over 72 hours.
- These w/o microemulsions possess characteristics suitable for parenteral preparations.
Related Concept Videos
In Vitro Drug Release Testing: Overview, Development and Validation
Preclinical Development: Overview
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
In Vitro Drug Dissolution: Alternative Methods

